Amedisys Inc. (AMED)

56.46
NASDAQ : Health Services
Prev Close 56.46
Day Low/High 0.00 / 0.00
52 Wk Low/High 45.60 / 65.91
Avg Volume 360.80K
Exchange NASDAQ
Shares Outstanding 33.94M
Market Cap 1.88B
EPS 1.10
P/E Ratio 33.02
Div & Yield N.A. (N.A)

Latest News

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Watch: Former Humana Executive Supports the CVS-Aetna Deal

Paul Kusserow, CEO of home health care provider Amedysis and a former Humana executive, thinks CVS Health's agreement to buy Aetna, announced on Monday, is "very exciting."

Short Interest Moves 12% Lower For AMED

The most recent short interest data has been released for the 11/15/2017 settlement date, which shows a 350,029 share decrease in total short interest for Amedisys, Inc. , to 2,541,688, a decrease of 12.10% since 10/31/2017.

AMED Crosses Above Average Analyst Target

In recent trading, shares of Amedisys, Inc. have crossed above the average analyst 12-month target price of $57.25, changing hands for $58.49/share.

2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide

2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide

158 Amedisys Home Health Care Centers Recognized

Short Interest In Amedisys Drops 16.8%

The most recent short interest data has been released for the 07/31/2017 settlement date, which shows a 553,082 share decrease in total short interest for Amedisys, Inc. , to 2,731,061, a decrease of 16.84% since 07/14/2017.

Amedisys Reports First Quarter 2017 Financial Results

Announces Closure of Acquisition of Home Health and Hospice Care Centers From Tenet Healthcare

Amedisys Reaches Analyst Target Price

In recent trading, shares of Amedisys, Inc. have crossed above the average analyst 12-month target price of $54.00, changing hands for $54.02/share.

TheStreet Quant Rating: B (Buy)